Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Drop in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Drop in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 262,000 shares, a decrease of 44.3% from the August 15th total of 470,600 shares. Based on an average daily volume of 953,800 shares, the short-interest ratio is presently 0.3 days.
费森尤斯医疗保健股份公司(纽约证券交易所代码:fms-GET评级)是8月份空头股数价格大幅下降的接受者。截至8月31日,空头股数共有26.2万股,比8月15日的47.06万股减少了44.3%。以日均成交量953,800股计算,目前短息比率为0.3天。
Fresenius Medical Care AG & Co. KGaA Stock Down 0.7 %
费森尤斯医疗保健股份公司KGaA股价下跌0.7%
NYSE:FMS traded down $0.12 on Friday, hitting $16.67. 1,785,818 shares of the company's stock were exchanged, compared to its average volume of 1,010,924. The firm has a 50-day moving average price of $19.14 and a 200-day moving average price of $26.32. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.18 and a quick ratio of 0.85. Fresenius Medical Care AG & Co. KGaA has a 52 week low of $16.06 and a 52 week high of $36.84. The company has a market cap of $9.77 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 0.84 and a beta of 1.03.
纽约证券交易所:FMS周五下跌0.12美元,触及16.67美元。该公司股票成交量为1,785,818股,而其平均成交量为1,010,924股。该公司的50日移动均线价格为19.14美元,200日移动均线价格为26.32美元。该公司的债务权益比为0.47,流动比率为1.18,速动比率为0.85。费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股价为52周低点16.06美元,52周高点为36.84美元。该公司市值为97.7亿美元,市盈率为10.62倍,市盈率为0.84倍,贝塔系数为1.03。
Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA
机构投资者看好Fresenius Medical Care AG&Co.KGaA
Institutional investors and hedge funds have recently modified their holdings of the company. FDx Advisors Inc. bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $315,000. Freestone Capital Holdings LLC bought a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter valued at about $390,000. Guardian Capital Advisors LP raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 10.7% in the 1st quarter. Guardian Capital Advisors LP now owns 52,148 shares of the company's stock valued at $1,744,000 after purchasing an additional 5,045 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 18.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 4,706 shares of the company's stock valued at $158,000 after purchasing an additional 730 shares during the period. Finally, Cacti Asset Management LLC raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 35.8% in the 1st quarter. Cacti Asset Management LLC now owns 36,000 shares of the company's stock valued at $1,212,000 after purchasing an additional 9,500 shares during the period. 5.59% of the stock is owned by institutional investors.
机构投资者和对冲基金最近调整了对该公司的持股。FDX Advisors Inc.在第一季度购买了费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的新股,价值约315,000美元。Frestone Capital Holdings LLC在第一季度购买了费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的新股,价值约39万美元。第一季度,Guardian Capital Advisors LP将费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票持有量增加了10.7%。在此期间,Guardian Capital Advisors LP又购买了5,045股,现在拥有52,148股该公司股票,价值1,744,000美元。西北共同财富管理公司第一季度增持了费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票18.4%。西北共同财富管理公司目前持有该公司4,706股股票,价值15.8万美元,在此期间又购买了730股。最后,Cacti Asset Management LLC在第一季度增持了费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的股票35.8%。Cacti Asset Management LLC在此期间又购买了9500股,现在拥有3.6万股该公司股票,价值121.2万美元。5.59%的股票由机构投资者持有。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
About Fresenius Medical Care AG & Co. KGaA
关于费森尤斯医疗保健股份公司
(Get Rating)
(获取评级)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Fresenius Medical Care AG&Co KGaA在德国、北美和国际上提供透析护理和相关的透析护理服务。它通过门诊透析诊所网络提供透析治疗以及相关的实验室和诊断服务;材料、培训和患者支持服务,包括临床监测、后续援助和安排将用品运送到患者住所;以及根据合同向美国医院提供为住院的终末期肾病(ESRD)患者和急性肾功能衰竭患者提供的透析服务。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- 免费获取StockNews.com关于Fresenius Medical Care AG&Co.KGaA(FMS)的研究报告。
- 股市:红海中的三座强国
- 第四季度值得考虑的3家银行
- 有什么办法可以治愈Teladoc股票的问题吗?
- MarketBeat:回顾一周9/12-9/16
- 没有人告诉这三只股票这是下跌的一周
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
接受Fresenius Medical Care AG&Co.KGaA Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Fresenius Medical Care AG&Co.KGaA和相关公司的最新新闻和分析师评级的每日简要摘要。